FDA says Pfizer Covid vaccine benefits outweigh risks for kids ages 5 to 11

NBC News
NBC News

Cover picture for the articleFederal health regulators said late Friday that kid-size doses of Pfizer’s Covid-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters. The Food and Drug Administration posted its analysis of Pfizer’s data...

Comments / 3

Comments / 0